Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation.

Baker, Hailey A; Brown, Alexandra R; Mahnken, Jonathan D; Shireman, Theresa I; Webb, Carol E; Lipe, Brea C

Baker, Hailey A; Brown, Alexandra R; Mahnken, Jonathan D; Shireman, Theresa I; Webb, Carol E; Lipe, Brea C.

Afiliación

Baker HA; University of Kansas School of Medicine, Wichita, Kansas.
Brown AR; University of Kansas Medical Center, Kansas City, Kansas.
Mahnken JD; University of Kansas Medical Center, Kansas City, Kansas.
Shireman TI; Brown University School of Public Health, Providence, Rhode Island.
Webb CE; University of Kansas Cancer Center, Kansas City, Kansas.
Lipe BC; University of Rochester Medical Center, Rochester, New York.

Cancer Med ; 8(1): 455-462, 2019 01.

Article en En | MEDLINE | ID: mdl-30585435

Asunto(s)

Anticoagulantes/uso terapéutico; Mieloma Múltiple/tratamiento farmacológico; Tromboembolia Venosa/prevención & control; Femenino; Humanos; Masculino; Persona de Mediana Edad; Guías de Práctica Clínica como Asunto; Factores de Riesgo

Palabras clave

guidelines; multiple myeloma; risk; thromboprophylaxis; venous thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tromboembolia Venosa / Mieloma Múltiple / Anticoagulantes Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google